{
  "id": [
    "32157600"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32157600"
  ],
  "pmcid": [
    "PMC7211204"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7211204"
      ]
    }
  ],
  "doi": [
    "10.1007/s40259-020-00412-3"
  ],
  "title": [
    "In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies."
  ],
  "authorString": [
    "Patel A, Bah MA, Weiner DB."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Patel A"
          ],
          "firstName": [
            "Ami"
          ],
          "lastName": [
            "Patel"
          ],
          "initials": [
            "A"
          ],
          "authorId": [
            {
              "_": "0000-0002-2104-9984",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Bah MA"
          ],
          "firstName": [
            "Mamadou A"
          ],
          "lastName": [
            "Bah"
          ],
          "initials": [
            "MA"
          ],
          "authorId": [
            {
              "_": "0000-0002-3238-1085",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Weiner DB"
          ],
          "firstName": [
            "David B"
          ],
          "lastName": [
            "Weiner"
          ],
          "initials": [
            "DB"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA. dweiner@wistar.org."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0002-2104-9984",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-3238-1085",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data",
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "3"
      ],
      "volume": [
        "34"
      ],
      "journalIssueId": [
        "2953814"
      ],
      "dateOfPublication": [
        "2020 Jun"
      ],
      "monthOfPublication": [
        "6"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-06-01"
      ],
      "journal": [
        {
          "title": [
            "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"
          ],
          "ISOAbbreviation": [
            "BioDrugs"
          ],
          "medlineAbbreviation": [
            "BioDrugs"
          ],
          "NLMid": [
            "9705305"
          ],
          "ISSN": [
            "1173-8804"
          ],
          "ESSN": [
            "1179-190X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "273-293"
  ],
  "abstractText": [
    "Antibody immunotherapy is revolutionizing modern medicine. The field has advanced dramatically over the past 40Â years, driven in part by major advances in isolation and manufacturing technologies that have brought these important biologics to the forefront of modern medicine. However, the global uptake of monoclonal antibody (mAb) biologics is impeded by biophysical and biochemical liabilities, production limitations, the need for cold-chain storage and transport, as well as high costs of manufacturing and distribution. Some of these hurdles may be overcome through transient in vivo gene delivery platforms, such as non-viral synthetic plasmid DNA and messenger RNA vectors that are engineered to encode optimized mAb genes. These approaches turn the body into a biological factory for antibody production, eliminating many of the steps involved in bioprocesses and providing several other significant advantages, and differ from traditional gene therapy (permanent delivery) approaches. In this review, we focus on nucleic acid delivery of antibody employing synthetic plasmid DNA vector platforms, and RNA delivery, these being important approaches that are advancing simple, rapid, in vivo expression and having an impact in animal models of infectious diseases and cancer, among others."
  ],
  "affiliation": [
    "Vaccine and Immunotherapy Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "OPP1163327"
          ],
          "agency": [
            "Bill and Melinda Gates Foundation"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "R01 AI141236"
          ],
          "agency": [
            "NIAID NIH HHS"
          ],
          "acronym": [
            "AI"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "OPP1201239"
          ],
          "agency": [
            "Bill and Melinda Gates Foundation"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "U19 AI142777"
          ],
          "agency": [
            "NIH HHS"
          ],
          "acronym": [
            "NH"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "R01AI141236"
          ],
          "agency": [
            "NIH HHS"
          ],
          "acronym": [
            "NH"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "U19 AI142777"
          ],
          "agency": [
            "NIAID NIH HHS"
          ],
          "acronym": [
            "AI"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1007/s40259-020-00412-3"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7211204"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7211204?pdf=render"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "32240503"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "BioDrugs. 2020 Apr 2;:"
          ],
          "type": [
            "Erratum in"
          ],
          "orderIn": [
            "1"
          ]
        },
        {
          "id": [
            "32623068"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "J Allergy Clin Immunol. 2020 Sep;146(3):537-540"
          ],
          "type": [
            "Comment in"
          ],
          "orderIn": [
            "2"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "1"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct",
        "doi"
      ]
    }
  ],
  "dateOfCreation": [
    "2020-03-12"
  ],
  "firstIndexDate": [
    "2020-03-12"
  ],
  "fullTextReceivedDate": [
    "2020-07-09"
  ],
  "dateOfRevision": [
    "2020-07-17"
  ],
  "firstPublicationDate": [
    "2020-06-01"
  ]
}